Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis

Comorbidity burden in patients with chronic GVHD

(2013) W A Wood et al.   BONE MARROW TRANSPLANTATION

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study

(2013) A. Gratwohl et al.   HAEMATOLOGICA

Defining the Role of Sirolimus in the Management of Graft-versus-Host Disease: From Prophylaxis to Treatment

(2012) Ahmed Abouelnasr et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?

(2012) Y P L Linhares et al.   BONE MARROW TRANSPLANTATION

TLI in refractory chronic GVHD

(2012) R Devillier et al.   BONE MARROW TRANSPLANTATION

Chronic Graft versus Host Disease but not the Intensity of Conditioning has Impact on Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Hematological Diseases

(2012) Inken Hilgendorf et al.   ONKOLOGIE

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation

(2011) Y. Inamoto et al.   BLOOD

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

(2011) José Baselga et al.   NEW ENGLAND JOURNAL OF MEDICINE

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Therapy of Sclerodermatous Chronic Graft-Versus-Host Disease with Mammalian Target of Rapamycin Inhibitors

(2010) Zuzana Jedlickova et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Phase 3 trial of everolimus for metastatic renal cell carcinoma

(2010) Robert J. Motzer et al.   CANCER

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative Analysis of Adverse Events Requiring Suspension of mTOR Inhibitors: Everolimus versus Sirolimus

(2010) A.I. Sánchez-Fructuoso et al.   TRANSPLANTATION PROCEEDINGS

Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial

(2009) Uwe Platzbecker et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center

(2009) A. Rodríguez-Moreno et al.   TRANSPLANTATION PROCEEDINGS

Therapy of chronic graft-versus-host disease

(2008) Mukta Arora   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials

(2008) Ana I Sánchez-Fructuoso   Expert Opinion on Drug Metabolism & Toxicology

Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning

(2008) Philippe Armand et al.   JOURNAL OF CLINICAL ONCOLOGY